MIM
Monashee Investment Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-50,000
| Closed | -$2.52M | – | 74 |
|
|
2024
Q3 | $2.52M | Hold |
50,000
| – | – | 0.27% | 54 |
|
|
2024
Q2 | $2.2M | Sell |
50,000
-65,000
| -57% | -$2.86M | 0.28% | 39 |
|
|
2024
Q1 | $5.78M | Buy |
+115,000
| New | +$5.78M | 0.68% | 23 |
|
|
2023
Q4 | – | Sell |
-50,000
| Closed | -$2.85M | – | 71 |
|
|
2023
Q3 | $2.85M | Hold |
50,000
| – | – | 1.19% | 32 |
|
|
2023
Q2 | $2.55M | Buy |
+50,000
| New | +$2.55M | 0.61% | 32 |
|
|
2022
Q4 | – | Sell |
-191,945
| Closed | -$1.49M | – | 57 |
|
|
2022
Q3 | $1.49M | Sell |
191,945
-8,055
| -4% | -$62.5K | 0.55% | 30 |
|
|
2022
Q2 | $1.05M | Buy |
+200,000
| New | +$1.05M | 0.38% | 19 |
|